CAS Number75985-31-8
Synonyms1(2H)-Pyridinecarboxylic acid,6-cyano-3,4-dihydro-,methyl ester; 2-Cyan-1-[(2-methoxy-6-methyl-pyridin-3-yl)-methyl]-aziridine; 2-cyano-1-[(2-methoxy-6-methylpyridin-3-yl)-methyl]-aziridine; 2-cyano-1,4,5,6-tetrahydro-1-pyridinecarboxylic acid methyl ester
Molecular FormulaC11H13N3O
Molecular Weight203.24
Purity98.00%
Density1.2g/cm3
Boiling Point327ºC at 760 mmHg
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 75985-31-8 |
| Catalog No. | 2A-9009769 |
| Chinese Name | 腈美克松 |
| Synonyms | 1(2H)-Pyridinecarboxylic acid,6-cyano-3,4-dihydro-,methyl ester; 2-Cyan-1-[(2-methoxy-6-methyl-pyridin-3-yl)-methyl]-aziridine; 2-cyano-1-[(2-methoxy-6-methylpyridin-3-yl)-methyl]-aziridine; 2-cyano-1,4,5,6-tetrahydro-1-pyridinecarboxylic acid methyl ester |
| Molecular Formula | C11H13N3O |
| Molecular Weight | 203.24 |
| Purity | 98.00 |
| Density | 1.2g/cm3 |
| Boiling Point | 327ºC at 760 mmHg |
| Application | Ciamexon is a novel immunomodulator that has promising effects in experimental models of autoimmune diseases and shows little to no cytotoxicity. Ciamexon can be used to study endocrine eye disease an |
| HTC | 2933990090 |
| MDL Number | C11H13N3O |
| SMILES | COc1nc(C)ccc1CN1CC1C#N |
| InChI | InChI=1S/C11H13N3O/c1-8-3-4-9(11(13-8)15-2)6-14-7-10(14)5-12/h3-4,10H,6-7H2,1-2H3 |
| InChI Key | KOYMTVWMCXDJNV-UHFFFAOYSA-N |
| MSDS | msds/9769_1_75985_31_8.pdf |
| Use of | Ciamexon is a novel immunomodulator that has shown promising results in experimental models of autoimmune disease with little demonstrated cytotoxicity.Ciamexon can be used to study endocrine ophthalmopathies and diabetes mellitus, with slight improvement in ophthalmic disease following short-term administration. Properties Name 1-[(2-Methoxy-6-methyl-3-pyridinyl)methyl]-2-aziridinecarbonitril e Synonym More Synonyms Biological Activity Description Ciamexon is a novel immunomodulator that has shown promising results in experimental models of autoimmune disease with little demonstrated cytotoxicity.Ciamexon can be used to study endocrine ophthalmopathies and diabetes mellitus, with slight improvement in ophthalmic disease following short-term administration. References 1. Kiesel U, et al. Suppression of spontaneous insulin-dependent diabetes in BB rats by administration of ciamexone. J Immunopharmacol. 1986;8(3):393-406. Chemical & Physical Properties Molecular Formula C11H13N3O Exact Mass 203.10600 PSA 48.92000 LogP 1.04428 Index of Refraction 1.573 InChIKey KOYMTVWMCXDJNV-UHFFFAOYSA-N Safety Information HS Code 2933990090 |
| Tax Rebate | 13.0% |
| Supervision | None. MFN tariff: 6.5%. Ordinary tariff: 20.0% |
| Transport Info | Product name: Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| Chlorthalidone | 77-36-1 | 2A-9009763 |
| Chlozolinate | 84332-86-5 | 2A-9009764 |
| Cholesttramine resin | 11041-12-6 | 2A-9009765 |
| Chromomycin A3 | 7059-24-7 | 2A-9009767 |
| Chymostatin | 9076-44-2 | 2A-9009768 |
| Cianergoline | 74627-35-3 | 2A-9009770 |
| Cibenzoline | 53267-01-9 | 2A-9009771 |
| Cibenzoline succinate | 100678-32-8 | 2A-9009772 |
| Cicarperone | 54063-29-5 | 2A-9009773 |
| Ciclesonide | 126544-47-6 | 2A-9009776 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA
EN
SDS